Publicaciones (297) Publicaciones de Juan Manuel Irache Garreta

2024

  1. Mucus-penetrating and permeation enhancer albumin-based nanoparticles for oral delivery of macromolecules: Application to bevacizumab

    Drug Delivery and Translational Research, Vol. 14, Núm. 5, pp. 1189-1205

  2. Targeting and activation of macrophages in leishmaniasis. A focus on iron oxide nanoparticles

    Frontiers in Immunology, Vol. 15

  3. Zein nanoparticles extend lifespan in C. elegans and SAMP8 mice

    International Journal of Pharmaceutics, Vol. 666

2023

  1. 3D printing of microencapsulated Lactobacillus rhamnosus for oral delivery

    International Journal of Pharmaceutics, Vol. 641

  2. Editorial: Protein nanoparticles: characterization and pharmaceutical application

    Frontiers in Pharmacology

  3. Encapsulation of Lactobacillus plantarum in casein-chitosan microparticles facilitates the arrival to the colon and develops an immunomodulatory effect

    Food Hydrocolloids, Vol. 136

  4. Gliadin nanoparticles for oral administration of bioactives: Ex vivo and in vivo investigations

    International Journal of Biological Macromolecules, Vol. 249

  5. Nanoparticle-based products: An example of complex dosage forms

    Time-Proof Perspectives on Bioequivalence (Nova Science Publishers, Inc.), pp. 253-273

  6. Optimization of Enterotoxigenic Escherichia coli (ETEC) Outer Membrane Vesicles Production and Isolation Method for Vaccination Purposes

    Microorganisms, Vol. 11, Núm. 8

  7. Zein-based nanospheres and nanocapsules for the encapsulation and oral delivery of quercetin

    International Journal of Pharmaceutics, Vol. 643

2022

  1. Development of a Bacterial Nanoparticle Vaccine Against Escherichia coli

    Methods in Molecular Biology (Humana Press Inc.), pp. 357-365

  2. Effect of topical berberine in murine cutaneous leishmaniasis lesions

    Journal of Antimicrobial Chemotherapy, Vol. 77, Núm. 4, pp. 1072-1081

  3. Immune Response after Skin Delivery of a Recombinant Heat-Labile Enterotoxin B Subunit of Enterotoxigenic Escherichia coli in Mice

    Pharmaceutics, Vol. 14, Núm. 2

  4. Oral Immunogenicity of Enterotoxigenic Escherichia coli Outer Membrane Vesicles Encapsulated into Zein Nanoparticles Coated with a Gantrez® AN–Mannosamine Polymer Conjugate

    Pharmaceutics, Vol. 14, Núm. 1

  5. Oral administration of zein-based nanoparticles reduces glycemia and improves glucose tolerance in rats

    International Journal of Pharmaceutics, Vol. 628

  6. Zein-Based Nanoparticles as Oral Carriers for Insulin Delivery

    Pharmaceutics, Vol. 14, Núm. 1

2021

  1. 3,5-Dimethyl-4-isoxazoyl selenocyanate as promising agent for the treatment of Leishmania infantum-infected mice

    Acta Tropica, Vol. 215

  2. Caenorhabditis elegans as a model under hyperglicemic conditions to evaluate insulin-loaded nanoparticles

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 202-204

  3. Changes in the nanoparticle uptake and distribution caused by an intramacrophagic parasitic infection

    Nanoscale, Vol. 13, Núm. 41, pp. 17486-17503

  4. Development of nanostructured systems using natural polymers to optimize the treatment of inflammatory bowel diseases: A prospective study

    Journal of Drug Delivery Science and Technology, Vol. 64